JUL 17, 2017 03:41 PM PDT

Cancer Forces Cells to Become Virus-Like

WRITTEN BY: Xuan Pham

For a long time, scientists noticed that tumors secrete factors that suggest there were viruses present inside the tumors too. But even when they searched high and low, no viruses were found within the tumors. But a recent study has finally unveiled the mystery: cancer cells force nearby healthy cells to secrete viral-like proteins for its defense.

Image credit: Pixabay.com

"The conundrum was that in most cases, there was no viral infection in these tumors," said Andy J. Minn, an associate professor of Radiation Oncology at Penn, and the study’s senior author. "We've been studying this problem for many years, and it's a puzzle we were motivated to solve because cancers with this kind of anti-viral signaling can be particularly aggressive."

Minn and his team found that the cancer cells force surrounding fibroblasts to secrete vial-like genetic material inside small fluid-filled sacs known as exosomes. Specific to breast cancer cells, the fibroblasts were making exosomes rich in an RNA known as RN7SL1 , which resembles viral RNA at one end. With this viral-mimic exposed, the tissue responds as if there are viruses present, and this response can further enable the growth of the tumor.

"The ability of cancer cells to specifically instruct the fibroblasts to expose the viral-like end of RN7SL1 is a key discovery," said Minn. "If the end remains covered, breast cancer cells wouldn't treat these exosomes like a virus, making them less likely to progress and more likely to respond to treatment. On the other hand, if the end is always exposed, cells would react as if they are infected with a virus all the time."

The researchers think this manipulation of fibroblast cells could explain the inflammatory nature of some aggressive types of breast cancers. In particular, triple-negative and BRCA1 are two aggressive types of breast cancers that have high viral responses. Singling out the mechanism behind this response could lead to specific alternative treatments that improve the outcomes for these cancer types.

"Since we can test the blood of cancer patients to measure the presence of exposed RN7SL1 in exosomes, we can potentially identify patients whose cancers will be the most aggressive because of this virus mimic," Minn said. "Now that we understand how the exposed RNA is generated, we can look to potential therapeutic targets."

Additional source: Perelman School of Medicine at the University of Pennsylvania

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 17, 2018
Cancer
JUL 17, 2018
Experimental "Trojan Horse" Tumor Destruction Approach Using CRISPR
CRISPR can be used to dupe circulating tumor cells into killing their own main tumor after "re-homing" back with a death receptor for tumor destruction....
JUL 24, 2018
Cancer
JUL 24, 2018
Transfection, Transduction, and CRISPR...Oh My
CRISPR gene editing came about based on transfection and transduction type models of genetic transfer. There is potential for it to revolutionize gene editing but are there dangers lurking?...
SEP 20, 2018
Genetics & Genomics
SEP 20, 2018
Liquid Phase Separation may Play a Role in Cancer
Not all liquids mix, like oil and water; the phenomenon is called liquid-liquid phase separation. We're learning more about its role in cells....
OCT 05, 2018
Cancer
OCT 05, 2018
FDA approves a new drug for an advanced type of skin cancer
As cancer is one of the most challenging diseases in our world, many efforts have been put into researching new ways for treatment to find new drugs that could help more patients worldwide. A...
NOV 02, 2018
Cell & Molecular Biology
NOV 02, 2018
Natural Molecule Enables Obese Mice to Shed Weight
A molecule that has been a focus of cancer research has been found to be a significant regulator of metabolism....
NOV 14, 2018
Immunology
NOV 14, 2018
Rapid Tumor Targeting
Researchers at the University of California Irvine have developed a technology that will rapidly identify and target T cell receptors for tumor specific antigens...
Loading Comments...